FindTrial
Sign In

Effect of Vitamin D supplementation on sarcopenia on type 2 Diabetes population.

Efficacy of Vitamin D supplementation on sarcopenia at risk and body fat distribution among middle aged type 2 Diabetes population - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067995
Enrollment
258
Registered
2024-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Cholecalciferol: High dose 60000 iu of cholecalciferol once a week per oral for 3 month Control Intervention1: Cholecalciferol: Low dose group (600IU of cholecalciferol daily per oral

Sponsors

Datta meghe institute of higher education and medical research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Hypovitaminosis D Type 2 Diabetes mellitus Age 20 to 60 years Both male and females

Exclusion criteria

Exclusion criteria: Acutely ill Acute Coronary Syndrome Chronic Kidney Disease Stroke Peripheral Neuropathy or any other Neurological diseases • Muscular diseases • Fractures • Persons having Bone metabolism

Design outcomes

Primary

MeasureTime frame
The impact of vitamin d3 supplementation using Sarc F questionnaire and hand grip testTimepoint: baseline, 3 months—

Secondary

MeasureTime frame
Vitamin D 3 levels & Hba1cTimepoint: Baseline & after 3 months—

Countries

India

Contacts

Public ContactPriyanka Negandhi

jawaharlal nehru medical college of higher education and medical research

drshilpagaidhane@gmail.com9673288822

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026